1. Home
  2. Press release
Jan 12, 2011 12:43 JST

Source: China Medical System Holdings Limited

China Medical System Holdings Issues FY2010 Earnings Guidance

HONG KONG, Jan 12, 2011 - (ACN Newswire) - China Medical System Holdings Ltd. (HKSE:0867) expects to release its results for the year ended 31 December 2010 in early March 2011.

As the leading provider of marketing, promotion and sales services for prescription drugs in China, CMS maintained its rapid growth in 2010.

The unaudited sales for the year ended 31 December 2010 are expected to be approximately US$132.2 million which represents a year over year growth of approximately 37%; up from US$96.5 million for the year ended 31 December 2009.

The strong sales growth was largely a result of our continuous promotion and marketing activities of our existing products.

Contact:
Quam IR 
Ms Anita Wan
Tel: +852-2217-2687
E-mail: anita.wan@quamgroup.com

Ms Sharon Au
Tel: +852-2217-2680
E-mail: sharon.au@quamgroup.com
  
Ms Venus Lam
Tel: +852-2217-2909
E-mail: venus.lam@quamgroup.com
Source: China Medical System Holdings Limited
Sectors: Daily Finance, BioTech

Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

Related Press Release

CMS (867.HK; 8A8.SG) NDA for AD Indication of Long-acting Anti-IL-4Ra Humanized Monoclonal Antibody Injection MG-K10 Accepted in China
October 30 2025 20:00 JST
 
CMS (867.HK; 8A8.SG) Signed A Distribution Agreement for Ophthalmic Drugs Lucentis(R) and Beovu(R)
October 27 2025 22:00 JST
 
China Medical System (867.HK; 8A8.SG) Positive Results from China Phase 3 Clinical Trial of Innovative Drug Ruxolitinib Cream with AD Indication
September 28 2025 15:00 JST
 
China Medical System (867.HK; 8A8.SG) Signed Collaboration Agreements for Two Innovative Biologics Used for Passive Immunization Against Tetanus and Rabies
September 23 2025 12:15 JST
 
CMS (867.HK, 8A8.SG) Reports Growth in Revenue and Profit for H1 2025, Strategic Transformation Unlocks New Drivers
August 19 2025 15:00 JST
 
China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China
July 29 2025 04:00 JST
 
CMS Collaborates with SGX to Explore New Paradigms for Industrial Globalization and Pharmaceutical Expansion Overseas across Emerging Markets
July 22 2025 13:00 JST
 
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia
April 01 2024 20:30 JST
 
China Medical System Accredited by 'China's Top 100 Potential Enterprises' by Forbes China for Two Consecutive Years
March 07 2011 15:00 JST
 
CMS Expects to Launch CMS024 for the Treatment of Primary Liver Carcinoma Three Years Ahead of Plan in 2013
January 28 2011 12:00 JST
 
More Press release >>

Latest Press Release


Hitachi High-Tech Announces the SU9600: Next-Generation Ultrahigh-Resolution Scanning Electron Microscope with High Throughput
Nov 01, 2025 00:45 JST

Sharp to Introduce AQUOS sense10 Smartphone
Nov 01, 2025 00:27 JST

Fujitsu to provide digital ticketing service for NTT DOCOMO's new d ticket platform
Nov 01, 2025 00:07 JST

HTD1801, a First-in-Class Anti-inflammatory Metabolic Modulator, Demonstrates Durable 52-Week Efficacy and Safety in Two Phase III Trials in Type 2 Diabetes Mellitus
Oct 31, 2025 09:30 JST

MHI and Nippon Shokubai to Develop Ammonia Cracking System for NEDO's "Development of Technologies for Building a Competitive Hydrogen Supply Chain" Project
Oct 30, 2025 23:14 JST

NEC and e& Sign MoU to Drive Joint Sustainability Initiatives
Oct 30, 2025 22:46 JST

MHI Thermal Systems Launches Two New Models of Air-to-Water Heat Pumps Using Natural Refrigerant R290 for European Market
Oct 30, 2025 22:19 JST

Hitachi Energy and Blackstone Energy Transition Partners enter strategic partnership to create leading energy service provider in North America
Oct 30, 2025 21:40 JST

MHI-MS to Conduct Demonstration Testing of Vehicle Transport Robots at Nakagusuku Port in Okinawa
Oct 30, 2025 17:58 JST

DENSO Hosted a Press Briefing at JAPAN MOBILITY SHOW 2025
Oct 30, 2025 17:29 JST

Eisai and Merck & Co., Inc., Rahway, NJ, USA Provide Update on Phase 3 LEAP012 Trial in Unresectable, Non-Metastatic Hepatocellular Carcinoma
Oct 30, 2025 14:43 JST

Mazda Presents World Premiere of Two Vision Models at Japan Mobility Show 2025
Oct 30, 2025 14:33 JST

Mazda Rolls Out New Version of Brand Symbol from Japan Mobility Show 2025

Oct 30, 2025 14:26 JST

NEC and the Cambodian Mine Action Center Successfully Predict Landmine-Contaminated Areas in Cambodia Using AI
Oct 30, 2025 14:18 JST

Overview of Honda CEO Speech at the Japan Mobility Show 2025
Oct 30, 2025 14:00 JST

Honda Presents World Premiere of the Prototype of Honda 0 a, new SUV Model for Honda 0 Series at Japan Mobility Show 2025
Oct 30, 2025 11:55 JST

Honda Presents World Premiere of Super-ONE Prototype Compact EV at Japan Mobility Show 2025
Oct 30, 2025 11:50 JST

Mitsubishi Motors Debuts Mitsubishi Elevance Concept and Adventure-Inspiring Lineup at Japan Mobility Show 2025
Oct 30, 2025 11:39 JST

Fujitsu and PwC Japan partner on economic security measures for sovereign cloud solution
Oct 30, 2025 11:22 JST

Hitachi Rail becomes world's first transportation firm to adopt new NVIDIA IGX Thor solution for real-time AI
Oct 30, 2025 11:00 JST
 More Latest Release >>